See All Slides - tctmd.com

Slides

Presentation TCT 2012

My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery)

Presenter: Rudiger Lange

October 22, 2012

Presentation TCT 2012

Mitral Valve Disease Hemodynamics, Balloon Valvuloplasty and the Edge-to-Edge Approach (Including Related Guidelines)

Presenter: Zoltan Turi

October 22, 2012

Presentation TCT 2012

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Presenter: Jeffrey Popma

October 22, 2012

Presentation TCT 2012

Should the Presence of Diabetes Affect Decisions on PCI vs. CABG, and Which DES to Choose?

Presenter: Duk-Woo Park

October 22, 2012

Presentation TCT 2012

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

“Nuggets” on Patient Selection After > 1,000 TAVR Cases (Performed and/or Proctored): Self-Expanding TAVR

Presenter: Ganesh Manoharan

October 22, 2012

Presentation TCT 2012

Early Insights on Cost-effectiveness After TAVR

Presenter: Matthew Reynolds

October 22, 2012

Presentation TCT 2012

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Presenter: John Webb

October 22, 2012

Presentation TCT 2012

Bioabsorbable Stents

Presenter: Hector Garcia-Garcia

October 22, 2012

Presentation TCT 2012

CTO Case Volumes and the Learning Curve: Insights from the European CTO Registry

Presenter: Carlo Di Mario

October 22, 2012

Advertisement

Slides

My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery)

Mitral Valve Disease Hemodynamics, Balloon Valvuloplasty and the Edge-to-Edge Approach (Including Related Guidelines)

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Should the Presence of Diabetes Affect Decisions on PCI vs. CABG, and Which DES to Choose?

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

“Nuggets” on Patient Selection After > 1,000 TAVR Cases (Performed and/or Proctored): Self-Expanding TAVR

Early Insights on Cost-effectiveness After TAVR

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Bioabsorbable Stents

CTO Case Volumes and the Learning Curve: Insights from the European CTO Registry

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content